Chan Lee has taken on the role as General Counsel at BeiGene.
Lee joins BeiGene from Sanofi and will bring his expertise leading legal functions in the biopharma industry to overseeing legal, compliance, intellectual property and related matters. He succeeds Scott Samuels, who built BeiGene’s global legal and compliance team and served as an important part of the company’s evolution to a global commercial organization.
Lee most recently served as North America General Counsel and Head of Legal for Specialty Care Global Business Unit at Sanofi, responsible for the legal oversight of Sanofi’s operations in the US and Canada and Specialty Care business globally. Prior to Sanofi, he held roles of increasing responsibility at Pfizer, most notably as Chief Counsel for Pfizer's Innovative Health global business. Earlier in his career, he served as Chief Counsel for the Vaccines, Oncology and Consumer Health global businesses at Pfizer, as well as Assistant General Counsel for its Asia operations.
Lee will serve on BeiGene’s Executive Committee and report directly to co-founder, chairman and CEO John V. Oyler.